| | | Good news for Gauzy. Alejandro Weinstein, a former board member of Gauzy has returned.
Alejandro Weinstein brings over 30 years of managerial experience in global companies. He previously served as CEO of CFR Pharmaceuticals S.A., where he transformed the business into a publicly listed global pharmaceutical enterprise that ultimately sold to Abbott Laboratories in a multi-billion-dollar transaction. His extensive experience in global expansion, M&A, and public company leadership will be instrumental as Gauzy scales its operations and advances its position as a leader in vision and light control technologies.
“We are excited to welcome Alejandro back to our Board,” said Eyal Peso, CEO and Chairman of Gauzy. “Alejandro brings invaluable experience as a CEO who successfully built a global leader in the pharmaceutical industry that went public under his leadership. His deep expertise in international growth, public company governance, and private equity will be instrumental as we continue to scale Gauzy’s global presence and deliver long-term value to our shareholders.”
Mr. Weinstein commented, “I am honored to be elected and returning to Gauzy's Board. As a longtime supporter of Gauzy, I continue to be inspired by its rapid expansion in the light and vision control market. I look forward to being an integral part in its future growth and creating long-term value for our shareholders.”
ND |
|
